Migraine Cure?

A new drug cuts migraine attacks by up to 75%.

20:49 05 April 2016

A new migraine treatment could very well be the “holy grail” drug after multiple trials showed that it could cut attacks by up to 75per cent. The discovery was well-received by millions of individuals who suffer from migraine, a condition that typically trigger dizziness, nausea and crippling pain.

 

Alder BioPharmaceuticals tried the drug, code-named ALD403, in 600 people and it showed that it slashed attacks by 75per cent in a third of patients.

 

The firm plans on carrying out further trials and hopes to make the drug available to patients in three years.

 

BioPharmaceuticals is one of the four major firms racing to be the first to introduce the first drug to treat migraine.  Its competitions are Amgen, Eli Lilly and Teva, each racing to get the first licence for the medication.

 

Professor Peter Goadsby, trustee of the UK Migraine Trust, said: ‘This is a huge development for migraine sufferers. There is no current specific treatment that has been developed for migraine.

 

‘The research has now come to a point where we understand the condition enough that we have worked out how to treat it.

 

‘All the studies that have been done are positive, and there has been an almost-embarrassing lack of side effects.

 

‘For a group of people who have never had a proper treatment, this is fantastic news.’